Since AFP, a protein expressed in HCC tumor cells, may be released by circulating or newly proliferating tumor cells after resection, relying solely on preoperative AFP levels limits prediction accuracy.11 As recurrence risk fluctuates over time, a time-updated model incorporating postoperative AFP levels may enhance prediction of recurrent disease. This evidence concerns the gene AFP and hepatocellular carcinoma.